What Happens When a Brain Implant Gives Someone Their Voice Back?
For most of us, sending an email, reading a bedtime story to a child, or doing our jobs are tasks we perform without a second thought. For Casey Harrell, a climate activist living with ALS, those same actions became nearly impossible as his disease progressed. Paralyzed and unable to speak coherently on his own, Harrell faced a shrinking world — until a small array of electrodes implanted in his brain changed everything. He now calls the technology "nothing short of revolutionary," and the researchers who work with him have given him a title that speaks for itself: the first power user of a brain implant.
Harrell's story sits at the center of a rapidly accelerating moment in neuroscience and medical technology. Brain-computer interfaces, or BCIs, are no longer the stuff of science fiction. They are active, improving, life-changing devices being tested in real people right now — and the pace of adoption is picking up faster than many expected.
Who Is Casey Harrell, and What Has He Been Able to Do?
Casey Harrell received his brain implant in July 2023, making him one of the earliest participants in what would become a growing wave of human BCI trials. The device, developed in collaboration with a team at the University of California, Davis, records electrical signals from neurons in the regions of his brain responsible for speech and movement. Those signals are then decoded by software and translated into text or synthesized speech in near real time.
In the nearly three years since his implantation, Harrell has used the technology to do things that ALS had taken away from him. He has held conversations with family members, reconnected with loved ones, continued his work as a climate activist, surfed the web independently, and — perhaps most poignantly — read to his daughter. These are not minor conveniences. For a man whose disease had otherwise closed off virtually every channel of independent expression, they represent a fundamental restoration of personhood.
The UC Davis team has not simply handed Harrell a static device and walked away. They have worked continuously with him to refine the system — improving its decoding accuracy, expanding the vocabulary it can reliably interpret, and introducing features like voice cloning, which allows the synthesized output to sound more like Harrell's own natural voice. This kind of ongoing collaboration between patient and research team is increasingly recognized as essential to making BCIs work in practice, not just in the lab.
The BCI Field Is Expanding Rapidly
Harrell's experience is remarkable on its own terms, but it also represents the leading edge of a much broader trend. Since 2024, the number of people worldwide who have been implanted with brain electrodes has more than doubled, reaching an estimated 150 individuals across multiple clinical trials. That figure may sound small, but in the context of a technology that involves placing electrodes directly on or inside the human brain, it represents a significant acceleration.
Several companies are driving this growth. Neuralink, founded by Elon Musk, has perhaps the highest public profile of any BCI company and has been conducting its own implantation trials. Synchron, an Australian-American startup, has developed a less invasive approach that threads a stent-like device into the brain through a blood vessel, eliminating the need for open-skull surgery. Meanwhile, Chinese firm Neuracle is running its own active trials, signaling that the development of this technology is becoming a genuinely global effort rather than one concentrated in a single country or region.
The rapid expansion of trials reflects both growing scientific confidence in the basic safety of these devices and increasing investor and institutional interest in the field. Regulatory agencies in the United States and elsewhere have begun developing clearer frameworks for evaluating and approving BCIs, which is helping companies move from early feasibility studies toward larger and more ambitious trials.
How the Technology Has Evolved
Early brain-computer interfaces were relatively limited in what they could do. The first generation of devices implanted in human patients were largely focused on cursor control — allowing a person to move a pointer on a screen by thinking about movement. That was genuinely useful, but it was also slow, cognitively demanding, and far removed from natural communication.
Today's systems are operating at an entirely different level. Researchers have achieved full speech decoding from neural signals, meaning that a device can interpret the brain's intended speech and convert it into words with meaningful accuracy and speed. Combined with voice cloning technology — which synthesizes speech that sounds like the patient's own pre-disease voice — modern BCIs can restore something that feels far closer to genuine conversation than a simple text cursor ever could.
Other capabilities under active development include fine motor control for robotic limbs, direct brain-to-computer typing, and even early explorations of restoring sensory feedback. The trajectory of improvement over the past decade has been steep, and researchers working in the field largely expect that trajectory to continue.
What We Still Don't Understand
Despite the progress, significant scientific questions remain unanswered. One of the most pressing is why BCI devices eventually stop working in some patients. Neural signals can degrade over time as the brain's tissue responds to the presence of a foreign object, forming scar tissue around electrodes and gradually weakening the quality of the signal being recorded. This is not a problem in every case, but it is unpredictable enough that researchers have not yet found a reliable way to prevent or reverse it.
Understanding the long-term biological relationship between brain tissue and implanted devices is one of the central challenges the field will need to solve if BCIs are to become durable, decades-long solutions rather than tools that fade after a few years. Materials science, bioengineering, and neuroscience are all being brought to bear on this problem, but a clear answer has not yet emerged.
What Brain-Computer Interfaces Mean for the Future
Casey Harrell's story is a powerful reminder of what is at stake in this research. For people living with ALS, spinal cord injuries, stroke, or other conditions that rob them of movement and speech, BCIs are not an abstract technological curiosity. They are a potential path back to independence, connection, and identity.
As trials expand, as companies compete and collaborate, and as the science deepens, brain-computer interfaces are moving steadily from experimental novelty toward clinical reality. The questions ahead are real and serious — about safety, longevity, access, ethics, and equity. But so is the promise. If the first power user of a brain implant can read to his daughter again, it is worth asking what the hundredth, or the thousandth, might be able to do.